Your session is about to expire
← Back to Search
Sleep Extension for Vascular Health (SAVHS Trial)
N/A
Recruiting
Research Sponsored by Auburn University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Free from metabolic disease
Age between 18 and 25 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change score from habitual sleep to day 15 (after 14 days of sleep extension)
Awards & highlights
SAVHS Trial Summary
This trial found that not getting enough sleep puts adults, especially those 18-25, at increased risk for cardiovascular disease and death. Poor sleep affects the heart and blood pressure, so getting 7-9 hours is important for health.
Who is the study for?
This trial is for young adults aged 18-25 who usually sleep less than 7 hours a night and don't have lung, metabolic, liver, or heart diseases. They should not have severe food allergies, eating disorders, high blood pressure (over 140/80 mmHg), a BMI over 35 kg/m2, be on blood thinners or have a history of sleeping disorders.Check my eligibility
What is being tested?
The study looks at whether increasing sleep to the recommended 7-9 hours can improve heart and metabolic health in young adults. It aims to understand how better sleep might lower the risk of cardiovascular disease by examining changes in participants' vascular function.See study design
What are the potential side effects?
Since this intervention involves non-medical methods like adjusting sleep patterns rather than taking drugs or undergoing surgery, side effects are minimal but may include temporary changes in mood or alertness.
SAVHS Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I do not have any metabolic diseases.
Select...
I am between 18 and 25 years old.
Select...
I do not have any lung diseases.
Select...
My liver is healthy.
Select...
I do not have any heart diseases.
SAVHS Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ change score from habitual sleep to day 15 (after 14 days of sleep extension)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change score from habitual sleep to day 15 (after 14 days of sleep extension)
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Blood pressure reactivity
Circulating Ghrelin
Circulating Leptin
+11 moreSecondary outcome measures
Appetite Assessment
Blood Cholesterol
Blood Glucose
+8 moreSAVHS Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Sleep extensionExperimental Treatment1 Intervention
Participants will extend their time in bed by one hour for 2 weeks while being monitored.
Group II: Habitual SleepActive Control1 Intervention
Participants will follow their normal sleep schedule for 2 weeks.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Sleep Extension
2017
N/A
~400
Find a Location
Who is running the clinical trial?
Auburn UniversityLead Sponsor
74 Previous Clinical Trials
14,403 Total Patients Enrolled
2 Trials studying Sleep
95 Patients Enrolled for Sleep
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have a history of sleeping disorders.I do not have any metabolic diseases.I am currently taking blood thinners.I am between 18 and 25 years old.You do not have serious food allergies or eating disorders.You usually sleep less than 7 hours per night.Your blood pressure is higher than 140/80 mmHg.I do not have any lung diseases.You weigh more than what is considered healthy for your height.My liver is healthy.I do not have any heart diseases.
Research Study Groups:
This trial has the following groups:- Group 1: Habitual Sleep
- Group 2: Sleep extension
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger